Literature DB >> 21044075

Regulation and role of cyclin-dependent kinase activity in neuronal survival and death.

Shin-ichi Hisanaga1, Ryo Endo.   

Abstract

Cyclin-dependent kinase (Cdk)5 is a proline-directed Ser/Thr protein kinase that functions mainly in neurons and is activated by binding to a regulatory subunit, p35 or p39. Kinase activity is mainly determined by the amount of p35 available, which is controlled by a balance between synthesis and degradation. Kinase activity is also regulated by Cdk5 phosphorylation, but the activity of phosphorylated Cdk5 is in contrast to that of cycling Cdks. Cdk5 is a versatile protein kinase that regulates multiple neuronal activities including neuronal migration and synaptic signaling. Further, Cdk5 plays a role in both survival and death of neurons. Long-term inactivation of Cdk5 triggers cell death, and the survival activity of Cdk5 is apparent when neurons suffer from stress. In contrast, hyper-activation of Cdk5 by p25 promotes cell death, probably by reactivating cell-cycle machinery in the nucleus. The pro-death activity is suppressed by membrane association of Cdk5 via myristoylation of p35. Appropriate activity, localization, and regulation of Cdk5 may be critical for long-term survival of neurons, which is more than 80 years in the case of humans.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044075     DOI: 10.1111/j.1471-4159.2010.07050.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  51 in total

1.  Astrocyte NMDA receptors' activity sustains neuronal survival through a Cdk5-Nrf2 pathway.

Authors:  D Jimenez-Blasco; P Santofimia-Castaño; A Gonzalez; A Almeida; J P Bolaños
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

2.  Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.

Authors:  Chun Shi; Keith Viccaro; Hyoung-Gon Lee; Kavita Shah
Journal:  J Cell Sci       Date:  2016-03-09       Impact factor: 5.285

Review 3.  Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.

Authors:  Yoshinari Miyata; John Koren; Janine Kiray; Chad A Dickey; Jason E Gestwicki
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

Review 4.  Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain.

Authors:  Kavita Shah; Sandra Rossie
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

5.  Heat shock inhibition of CDK5 increases NOXA levels through miR-23a repression.

Authors:  Trevor M Morey; Rabih Roufayel; Donald S Johnston; Andrew S Fletcher; Dick D Mosser
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

6.  The Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in a model of Alzheimer's disease.

Authors:  Kumar Nikhil; Kavita Shah
Journal:  J Cell Sci       Date:  2017-07-27       Impact factor: 5.285

7.  Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer's Disease Pathogenesis.

Authors:  Kumar Nikhil; Keith Viccaro; Kavita Shah
Journal:  Mol Neurobiol       Date:  2018-06-08       Impact factor: 5.590

8.  PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.

Authors:  Tatsuyoshi Kono; Geonyoung Ahn; Dan R Moss; Liann Gann; Angel Zarain-Herzberg; Yurika Nishiki; Patrick T Fueger; Takeshi Ogihara; Carmella Evans-Molina
Journal:  Mol Endocrinol       Date:  2012-01-12

9.  Decreasing Levels of the cdk5 Activators, p25 and p35, Reduces Excitotoxicity in Striatal Neurons.

Authors:  Kevin H J Park; Ge Lu; Jing Fan; Lynn A Raymond; Blair R Leavitt
Journal:  J Huntingtons Dis       Date:  2012

Review 10.  Phosphoregulation of the WAVE regulatory complex and signal integration.

Authors:  Michelle C Mendoza
Journal:  Semin Cell Dev Biol       Date:  2013-01-24       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.